Cardiac Function Improvement and Bone Marrow Response –

Cardiac Function Improvement and Bone Marrow Response –

Objective: The phase III clinical trial PERFECT was designed to assess clinical safety and efficacy of intramyocardial CD133+ bone marrow stem cell treatment combined with CABG for induction of cardiac repair. Design: Multicentre, double-blinded, randomised placebo controlled trial. Setting: The stu...

Full description

Bibliographic Details
Main Authors:	Gustav Steinhoff, Julia Nesteruk, Markus Wolfien, Günther Kundt, Jochen Börgermann, Robert David, Jens Garbade, Jana Große, Axel Haverich, Holger Hennig, Alexander Kaminski, Joachim Lotz, Friedrich-Wilhelm Mohr, Paula Müller, Robert Oostendorp, Ulrike Ruch, Samir Sarikouch, Anna Skorska, Christof Stamm, Gudrun Tiedemann, Florian Mathias Wagner, Olaf Wolkenhauer
Format:	Article
Language:	English
Published:	Elsevier 2017-08-01
Series:	EBioMedicine
Subjects:	Randomised double-blinded phase III multicentre trial CD133+ CD34+ Endothelial progenitor cell (EPC) SH2B3 Lnk adaptor Cardiac repair Cardiac stem cell therapy Angiogenesis
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417302967

Similar Items

Cover Research Handbook on International Law and Environmental Peacebuilding Research Handbook on International Law and Environmental Peacebuilding
Published: (2023)

Implication fonctionnelle de la protéine adaptatrice Lnk dans les cellules normales et pathologiques du lignage mégacaryocytaire
by: Magdoud, Hajer
Published: (2014)

Adaptor protein LNK promotes anaplastic thyroid carcinoma cell growth via 14-3-3 ε/γ binding
by: Zhao-Ming Zhong, et al.
Published: (2020-01-01)

Expression of CD133 in various premalignant and proliferative lesions
by: Rahmi Amtha, et al.
Published: (2015-06-01)

Expression of CD133 and CD24 and their different phenotypes in urinary bladder carcinoma
by: Farid RM, et al.
Published: (2019-05-01)

Sporadic multicentric right atrial and right ventricular myxoma presenting as acute pulmonary thromboembolism
by: Satyajit Singh, et al.
Published: (2016-01-01)

The CD133+ Stem/Progenitor-Like Cell Subset Is Increased in Human Milk and Peripheral Blood of HIV-Positive Women
by: Jacqueline María Valverde-Villegas, et al.
Published: (2020-09-01)

Stem cells from glomerulus to distal tubule: a never-ending story?
by: Melania Puddu, et al.
Published: (2016-08-01)

Date Palm (Phoenix dactylifera) Fruits as a Potential Cardioprotective Agent: The Role of Circulating Progenitor Cells
by: Ibrahim A. Alhaider, et al.
Published: (2017-09-01)

The Inhibitory Effect of Lysophosphatidylcholine on Proangiogenesis of Human CD34+ Cells Derived Endothelial Progenitor Cells
by: Haijun Zhao, et al.
Published: (2021-06-01)

Therapeutic Approaches to Target Cancer Stem Cells
by: Kalet Leon, et al.
Published: (2011-08-01)

The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
by: Yao-Li Chen, et al.
Published: (2017-07-01)

Perfil circadiano da expressão de microRNAs em células progenitoras CD133+
by: Marina Marçola
Published: (2015)

Perfil circadiano da expressão de microRNAs em células progenitoras CD133+
by: Marçola, Marina
Published: (2015)

UniCAR T cell immunotherapy enables efficient elimination of radioresistant cancer cells
by: Claudia Arndt, et al.
Published: (2020-01-01)

Differential number of CD34+, CD133+ and CD34+/CD133+ cells in peripheral blood of patients with congestive heart failure
by: Fritzenwanger M, et al.
Published: (2009-03-01)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

Clinicopathological and Prognostic Significance of Cancer Stem Cell Markers in Ovarian Cancer Patients: Evidence from 52 Studies
by: Yifeng Tao, et al.
Published: (2018-04-01)

CD133: a potential indicator for differentiation and prognosis of human cholangiocarcinoma
by: Wang Zhe, et al.
Published: (2011-07-01)

Gene expression profiling of circulating CD133+ cells of hepatocellular carcinoma patients associated with HCV infection
by: Abdel-Rahman N. Zekri, et al.
Published: (2017-03-01)

CD133-Positive Cells Might Be Responsible for Efficient Proliferation of Human Meningioma Cells
by: Xuanchun Wang, et al.
Published: (2012-05-01)

The Utilization and Limitation of CD133 Epitopes in Lung Cancer Stem Cells Research
by: Yin CHEN, et al.
Published: (2011-10-01)

CD133 expression in patients with peripheral neuroblastic tumor: a systematic review
by: Hedieh Nazarzadeh, et al.
Published: (2015-09-01)

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
by: Zeng Zhen, et al.
Published: (2012-12-01)

An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells
by: Daniel A. Vallera, et al.
Published: (2013-01-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

Biological properties of cord blood hematopoietic stem cells
by: S. A. Rumiantsev, et al.
Published: (2014-07-01)

Overexpression of Endogenous Retroviruses and Malignancy Markers in Neuroblastoma Cell Lines by Medium-Induced Microenvironmental Changes
by: Lisa Wieland, et al.
Published: (2021-05-01)

Prognostic and Clinical Value of CD44 and CD133 in Esophageal Cancer: A Systematic Review and Meta-analysis
by: Aseel Kamil Mohammed Al-mosawi, et al.
Published: (2020-04-01)

Inhibition of human prostate cancer (PC-3) cells and targeting of PC-3-derived prostate cancer stem cells with koenimbin, a natural dietary compound from Murraya koenigii (L) Spreng
by: Kamalidehghan B, et al.
Published: (2018-05-01)

Biological properties of cord blood hematopoietic stem cells
by: S. A. Rumiantsev, et al.
Published: (2014-07-01)

Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
by: Yiyi Zhang, et al.
Published: (2020-09-01)

Quantitative Cell Numbers and Density of Mesangial Volume in a Rat Model with Induced Hyperglycemic and Treated with Mononuclear Derived CD133 Positive Cells
by: Durdi Qujeq, et al.
Published: (2014-05-01)

Role of CD133 in human embryonic stem cell proliferation and teratoma formation
by: Hua Wang, et al.
Published: (2020-05-01)

CD133 Is Not Suitable Marker for Isolating Melanoma Stem Cells from D10 Cell Line
by: Motahareh Rajabi Fomeshi, et al.
Published: (2016-04-01)

The High Yield Expansion and Megakaryocytic Differentiation of Human Umbilical Cord Blood CD133+ Cells
by: Mahin Nikougoftar Zarif, et al.
Published: (2011-01-01)

Influence of CD133+ expression on patients' survival and resistance of CD133+ cells to anti-tumor reagents in gastric cancer
by: De-Hu Chen, et al.
Published: (2015-12-01)

CD133 does not enrich for the stem cell activity in vivo in adult mouse prostates
by: Xing Wei, et al.
Published: (2016-05-01)

CD133 expression in cancer cells predicts poor prognosis of non-mucin producing intrahepatic cholangiocarcinoma
by: Xiaobo Cai, et al.
Published: (2018-03-01)

MGMT promoter methylation status and MGMT and CD133 immunohistochemical expression as prognostic markers in glioblastoma patients treated with temozolomide plus radiotherapy
by: Melguizo Consolación, et al.
Published: (2012-12-01)